These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 3463631)

  • 1. [Utility of CA19-9 and CEA as tumor marker in colorectal cancer--comparison between serum level and distribution].
    Okuda K; Kodaira S; Watanabe M; Takami H; Teramoto T; Abe O; Iri H; Ino Y; Hirohashi S
    Nihon Gan Chiryo Gakkai Shi; 1986 Jun; 21(5):969-77. PubMed ID: 3463631
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ca 12-5 in stomach and colorectal cancer. A comparison with the tumor markers CEA and Ca 19-9].
    Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H
    Med Klin (Munich); 1986 Mar; 81(6):199-201. PubMed ID: 3466003
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparison of the tumor markers CEA and CA 19-9 in colorectal diagnosis].
    Heptner G; Domschke S; Krapf F; Schneider MU; Iro H; Domschke W
    Dtsch Med Wochenschr; 1984 Aug; 109(35):1309-12. PubMed ID: 6590287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor markers carcinoembryonic antigen, tissue polypeptide antigen, and carbohydrate antigen 19/9 in liver diseases.
    Putzki H; Ledwoch J; Student A; Jablonski M; Heymann H
    J Surg Oncol; 1988 Feb; 37(2):133-5. PubMed ID: 3278167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preoperative determination of carcinoembryonic antigen and gastrointestinal antigen in neoplastic colorectal pathology. Case contributions].
    Ramella A; Bussone R; Sanlorenzo M; Natta F; Caldarola B; Schirripa C; Giani R; Pecchio F; Rocca N
    Minerva Chir; 1987 Jun; 42(12):1037-43. PubMed ID: 3476864
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diagnosis and treatment of colorectal cancer using monoclonal antibodies].
    Inagi H; Okuda H; Shimano T; Kadota T; Mori T
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2291-7. PubMed ID: 3460528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Histopathological and immunohistochemical studies on the elevation mechanism of cancer associated antigens, CEA and CA19-9, in patients with colorectal cancer].
    Deguchi H; Tabuchi Y; Saitoh Y
    Nihon Geka Gakkai Zasshi; 1988 May; 89(5):671-83. PubMed ID: 3166103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Ca 12-5 as a tumor marker for gastric and colo-rectal cancer in comparison to CEA and Ca 19-9.
    Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H
    Eur J Surg Oncol; 1987 Jun; 13(3):197-201. PubMed ID: 3474158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical value of the tumor markers CA 19/9 and carcinoembryonic antigen (CEA) in colorectal carcinomas: a critical comparison.
    von Kleist S
    Int J Biol Markers; 1986; 1(1):3-8. PubMed ID: 3480321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of tumour markers (CEA, TPA, CA 19-9) in colon and rectum carcinomas.
    Cangemi V; Volpino P; Fiori E; Giammarco A; Piat G
    J Nucl Med Allied Sci; 1987; 31(2):189-93. PubMed ID: 3476692
    [No Abstract]   [Full Text] [Related]  

  • 11. [Advantages and limitations of combined assays of 4 serum markers in various types of malignant neoplasms].
    Lanza E; Coda C; Ramella S; Ciambellotti E; Moro G; Cartia GL
    Minerva Med; 1986 Sep; 77(34-35):1521-5. PubMed ID: 3463886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Carcinoembryonic antigen, CEA, in colorectal cancer. An insensitive marker which may be excluded from follow-ups].
    Wählby L
    Lakartidningen; 1997 Apr; 94(18):1716-8. PubMed ID: 9182180
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prognostic value of tumor markers in cases of colorectal cancer: CEA and CA 19-9].
    Desaive C; Servais R; Collette J; Denis D; Reginster JY; Franchimont P
    Acta Gastroenterol Belg; 1987; 50(1):65-78. PubMed ID: 3480671
    [No Abstract]   [Full Text] [Related]  

  • 14. [Significance of CEA and CA242 in the diagnosis of colorectal carcinoma].
    Wu J; Yu H; Shao Y
    Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):438-40. PubMed ID: 8697997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical evaluation of tumor markers in patients with colorectal cancer].
    Naritaka Y; Ogawa K; Matsumoto N; Hosokawa T; Kikuchi T; Koyama N; Haga S; Kajiwara T; Sakakibara N
    Gan No Rinsho; 1987 Aug; 33(10):1274-80. PubMed ID: 2444727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical evaluation of the tumor marker CA 19-9 in comparison with carcinoembryonic antigen (CEA) in surgical pre- and postoperative diagnosis].
    Lorenz M; Happ J; Hottenrott C; Maul FD; Baum RP; Hör G; Encke A
    Nuklearmedizin; 1986 Feb; 25(1):9-14. PubMed ID: 3459133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic and prognostic value of CEA and GICA in colo-rectal tumors. A caseload contribution].
    Lasagna B; Balbo G; De Paolis P; Sacchetti M
    Minerva Med; 1990 Nov; 81(11):769-71. PubMed ID: 2255411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of CA 19-9 in tumor after-care in stomach and colorectal cancer].
    Safi F; Rappenecker B; Roscher R; Beger HG
    Med Klin (Munich); 1986 Jan; 81(1):12-4. PubMed ID: 3466002
    [No Abstract]   [Full Text] [Related]  

  • 19. [CA-50 in serum of patients with carcinoma. Clinical experiences with a new tumor marker].
    Bruhn HD; Broers H; Euler H; Everding A; Feller AC; Hedderich J; Jostarndt L; Jooss B; Zurborn KH; Löffler H
    Dtsch Med Wochenschr; 1986 Aug; 111(34):1267-72. PubMed ID: 3461933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tumor markers in gastrointestinal cancer and its clinical significance].
    Taguchi T; Ota J; Sumida S; Rii M
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3004-9. PubMed ID: 3479051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.